Endometriosis: From Pain to Policy – A Growing Awareness and the Path to Better Care

“Your pain is normal,” “all women experience this,” “you have a low pain tolerance”—these are painfully familiar statements to many patients navigating the journey to an endometriosis diagnosis. Affecting approximately 190 million women of reproductive age globally, endometriosis remains significantly underdiagnosed, often dismissed or mistaken for other conditions. March marks Endometriosis Awareness Month, a time to raise awareness, advance clinical understanding, and strengthen support for those affected.

A History of Awareness

While the Endometriosis Association designated March as Endometriosis Awareness Month in 1993, broader recognition gained momentum in the 2010s, largely through social media platforms. Endometriosis is a chronic inflammatory condition where tissue similar to the uterine lining grows in other parts of the body. Common symptoms include severe menstrual pain, heavy bleeding, chronic pelvic pain, infertility, abdominal bloating, and nausea [1].

The Diagnostic Delay

Despite these debilitating symptoms, diagnosis often takes between 5 and 12 years [1]. This delay can exacerbate disease progression and pain. Contributing factors include a lack of awareness, education, and social stigma among both patients and healthcare providers. Patients may downplay symptoms or fear judgment, while clinicians may lack sufficient training and evidence-based guidance for treatment options.

Current Treatment Options

Currently, there is no definitive cure for endometriosis. Management typically focuses on symptom control and preventing long-term complications. This often involves nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and hormonal medications such as the contraceptive pill. Surgical treatment can remove endometriosis lesions, adhesions, and scar tissue, but complex cases involving multiple organs present significant surgical challenges [1].

The Funding Gap and Emerging Research

A significant barrier to improving endometriosis diagnosis and treatment is insufficient research funding. Between 2019 and 2023, less than 1% of healthcare research and development funding was allocated to female-specific conditions, highlighting a severe underinvestment in women’s health [1]. This scarcity of data often discourages further funding, perpetuating a cycle of underrepresentation. However, philanthropic efforts like the Ainsworth family’s $50 million commitment to establish the Ainsworth Endometriosis Research Institute (AERI) at the University of New South Wales are aiming to accelerate breakthroughs in diagnostics and precision-based treatments [1].

Policy and Comorbidities

Australia and France are currently the only two countries with national action plans (NAPs) for endometriosis [1]. While other countries, including Sweden, Canada, and Germany, are considering similar plans, more comprehensive action is needed. Recent research highlights the extensive comorbidity burden associated with endometriosis, including increased risks of irritable bowel syndrome, cardiovascular disease, depression, eating disorders, and anxiety [1]. A US multi-center study identified hundreds of conditions linked to endometriosis, emphasizing its systemic nature and the need for a broader approach to care.

Commercialization and Ethical Considerations

While policymakers have been gradual to prioritize women’s health, the healthcare industry is recognizing its commercial potential. A report by the Boston Consulting Group noted that “Better healthcare for women is quality business” [1]. This growing commercial interest raises ethical concerns about commodifying women’s health experiences. It is crucial to strategically utilize this momentum to promote health equity, ensuring women are viewed as partners, not products.

The Importance of Education and Amplifying Voices

Amplifying female voices and improving education are essential. Early education on endometriosis and menstrual health, starting at an appropriate age, empowers informed decision-making. Programs in Canada and New Zealand have demonstrated that teaching adolescents about menstrual health and endometriosis improves their knowledge and encourages earlier specialist care. In the US, the ENPOWR program is expanding endometriosis education to school nurses, recognizing the importance of equipping adults with the knowledge to support students. In Wales, endometriosis will be included in the mandatory menstrual cycle curriculum, recognizing menstrual health as a public health issue.

Looking Ahead

Endometriosis should be a central focus of women’s health research agendas. Recognizing and validating patients’ experiences must be integrated into policies. Journals and publishers should prioritize endometriosis awareness by highlighting research and amplifying patient voices. Efforts should focus on developing early, noninvasive diagnostics, establishing longitudinal cohorts, and conducting rigorous clinical trials. Improved training programs for hormone-based and pain-competent care are also crucial. Together, these steps will aid close the longstanding gaps in endometriosis recognition, diagnosis, and management.